SCIO Health Analytics®, a leading health analytics solution and services company, today announced that it was named to Healthcare Tech Outlook's, "20 Most Promising Healthcare Analytics Solution Providers" list for 2015. SCIO® was among the companies considered "at the forefront of tackling industry challenges," according to a distinguished panel of CEOs, CIOs, venture capitalists and analysts, including the Healthcare Tech Outlook editorial board that reviewed the top companies in the healthcare analytics space.
"SCIO's strength is in our unparalleled ability to accurately analyze data from multiple sources and develop actionable and predictive insights based on emerging risk," said Siva Namasivayam, CEO, SCIO Health Analytics. "By giving our clients the ability to efficiently and effectively manage the health of their population and engage patients/members in their care, as well as providing them with the tools to manage and optimize reimbursement, we can help them remain competitive and succeed in a continually evolving healthcare marketplace."
According to Healthcare Tech Outlook, "the next target for analytics is to be more prescriptive" by continuing to demonstrate suggested actions that make healthcare providers more successful, profitable or responsive to patients' needs.
Rose Higgins, SCIO's executive vice president and general manager, concurs. She notes that SCIO takes a comprehensive approach in identifying the most effective route for engaging with an individual in addressing gaps in care to optimize clinical outcomes.
"By understanding intervenable risk profiles and determining utilization trends, our clients can determine those areas that yield the greatest impactability opportunity for achieving the best clinical outcomes," she said.
In addition to being recognized by Healthcare Tech Outlook, SCIO was recently ranked as a major player in two IDC Health Insights' Marketscape reports: U.S. Healthcare Payer Fraud, Waste and Abuse Services 2015 Vendor Assessment, and U.S. Payer Data Analytics 2015 Vendor Assessment.
New platform enables unbiased evaluation of AI algorithms for diabetic eye screening